Sharpening the Target
- 2 September 2025
- journal article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (9) , 1010-1012
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of 18F-FAPI-42 PET for Detecting Cardiac Fibroblast Activation in Dilated Cardiomyopathy With Histopathology and CMRJACC: Cardiovascular Imaging, 2025
- Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic PrecisionJACC: Cardiovascular Imaging, 2025
- Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga]Ga-FAPI-04 PET/CMR imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Potential application of 68Ga-FAPI PET/CT for diagnosing cardiac sarcoidosisJournal of Nuclear Cardiology, 2024
- Functional significance of myocardial activity at 18F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Displays of 18F-FAPI PET/CT in Myocarditis With Variable Symptom DurationsClinical Nuclear Medicine, 2023
- CAR T cells produced in vivo to treat cardiac injuryScience, 2022
- The role of fibroblast activation protein in health and malignancyCancer and Metastasis Reviews, 2020
- Targeting cardiac fibrosis with engineered T cellsNature, 2019